Get started
Author

Sandeep Dhanda

Observed name: Dhanda, Sandeep
ORCID: 0000-0002-4831-2535
Observed ORCID: 0000-0002-4831-2535
OpenAlex ID: A5103129267
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
2020 · Vicki Osborne, Miranda Davies, et al. · Drug Safety · 70
PDF
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
2020 · Miranda Davies, Vicki Osborne, et al. · Drug Safety · 69
PDF
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
2020 · Sandeep Dhanda, Vicki Osborne, et al. · BMJ Evidence-Based Medicine · 39
PDF
A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events
2021 · Sandeep Dhanda, Alison Evans, et al. · Frontiers in Pharmacology · 12
PDF
Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States
2021 · Sigal Kaplan, Monica L. Bertoia, et al. · Contraception · 7
A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
2024 · Alison Evans, Debabrata Roy, et al. · Frontiers in Pharmacology · 5
Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database study
2021 · Sigal Kaplan, Massoud Toussi, et al. · Current Medical Research and Opinion · 5
Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study
2025 · Alison Evans, Debabrata Roy, et al. · BMJ Open · 4
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements
2026 · Dawn Cooper, Mohammed Toseef Ansari, et al. · Drug Safety · 2
Delayed pregnancy detection and return to fertility with extended levonorgestrel‐containing oral contraceptives: A real world setting cohort study
2022 · Sigal Kaplan, Monica L. Bertoia, et al. · Pharmacoepidemiology and Drug Safety · 2
Convalescent Plasma in treatment of COVID-19: A review of evidence for a living systematic benefit-risk assessment
2020 · Miranda Davies, Samantha Lane, et al. · medRxiv · 2
PDF
Enhanced passive safety surveillance (EPSS) of a seasonal intranasal influenza vaccine (Fluenz® Tetra) in children in England: methodology, results and lessons learned from eight influenza seasons (2015/2016 to 2022/2023)
2026 · Sandeep Dhanda, Denise E Morris, et al. · Vaccine
PDF
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a dynamic framework for rapid decision-making
2020 · Vicki Osborne, Miranda Davies, et al. · medRxiv
Works count: 15
Citation count: 217
H-index: 5
I10-index: 4
Year
Topic
Type